HIZER PHARMACEUTIAL
CONTENTS
o Introduction
o Worst case scenario
o Base case scenario
o Best case scenario
o Summary
Crypto: investing & trading
3
INTRODUCTION
o HIZER Pharmaceuticals is a leading drug
manufacturing company based in New York,
USA. With a strong commitment to
innovation, quality, and patient safety,
HIZER focuses on developing,
manufacturing, and marketing a wide range
of pharmaceutical products.
Crypto: investing & trading
WORST CASE SCENARIO
NPV for worst case NPV/IRR/PBP
o Worst case: o NPV (worst case):
o Market size: 780,000 (145,080,000 - 75,000,000)
/ (1 + 0.10) ^ 10 =
o Market share: 0.08 48,759,025
o Unit price: 550 o IRR (worst case): 13.28%
o Variable cost per unit: 450 o Payback period (worst case):
o Fixed cost per unit: 22 4.05 years
5
BASE CASE SCENARIO
Base (expected) NPV/IRR/PBP
case:
o NPV (base case):
Market size: (187,800,000 - 75,000,000)
860,000 / (1 + 0.10) ^ 10 =
82,703,572
Market share: 0.10 o IRR (base case): 19.25%
Unit price: 555 o Payback period (base
case): 4.02 years
Variable cost per
unit: 440
Fixed cost per unit:
20
Crypto: investing & trading
W E A LT H I S T H E A B I L I T Y
T O F U L LY E X P E R I E N C E
LIFE.
Best case scenario NPV/IRR/PBP
o Market size: 880,000 o NPV (best case):
o Market share: 0.12 (205,080,000 - 75,000,000)
/ (1 + 0.10) ^ 10 =
o Unit price: 560 95,573,488
o Variable cost per unit: 435 o IRR (best case): 22.96%
o Fixed cost per unit: 18 o Payback period (best case):
3.97 years
7
WHICH SCENARIO IS BEST ?
o In conclusion, based on
the information provided
in the three scenarios, the
Base (expected) case
scenario would be the
most appropriate one to
consider for the
investment decision. This
scenario provides a
WORST CASE BASE CASE realistic assessment of the
BEST CASE potential returns and risks
Crypto: investing & trading associated with investing
in HIZER Pharmaceuticals
8
T H A N K YO U
Crypto: investing & trading
